TNF and rheumatoid arthritis: In this regard, several studies have shown that anti-TNF therapy (based on the administration of infliximab, etanercept, or adalimumab) was able to reduce insulin resistance—measured by the HOMA-IR—in nondiabetic patients with RA [21,143,144,145].